Biomere

Executive Summary

Biomere (JOINN Biomere) is a preclinical contract research organization (CRO) headquartered in Worcester, MA, serving the East Coast drug development community. Founded in 1996, the company offers a comprehensive suite of early discovery and preclinical services, including in vivo pharmacology, toxicology, pharmacokinetics, and bioanalysis. Biomere holds AAALAC accreditation, OLAW Assurance, DEA licensure, and USDA registration, underscoring its commitment to regulatory compliance and animal welfare. With a team of 51-200 employees, the CRO provides a personalized, client-focused approach that distinguishes it from larger competitors. As the pharmaceutical industry increasingly outsources preclinical work, Biomere is well-positioned to capitalize on growing demand for specialized, high-quality contract research services. The company’s established track record and regulatory credentials make it a reliable partner for biotech and pharma clients seeking to advance drug candidates through the preclinical pipeline.

Upcoming Catalysts (preview)

• Q3 2026Expansion of service offerings or facility capacity40% success
• Q4 2026Strategic partnership or collaboration with a major pharma or biotech30% success
• Q2 2026Renewal or upgrade of key accreditations (e.g., AAALAC reaccreditation)80% success